AN OPEN-LABEL, NON-RANDOMIZED, MULTICENTER, TWO-STAGE, PHASE 2 STUDY OF S-1 IN CHEMOTHERAPY-NAIVE PATIENTS WITH LOCALLY ADVANCED OR METASTATIC PANCREATIC CANCER

Update Il y a 4 ans
Reference: EUCTR2005-003272-38

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

To evaluate the antitumor acitivity, as assessed by objective tumor response (overall response rate [ORR] of single agent S-1 in chemotherapy-naive patients with locally advanced or metastatic pancreatic cancer.


Inclusion criteria

  • Pancreatic cancer

Links